If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mariaelena Capone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Melanoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Genes Medicine & Life Sciences
Mutation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
interferon alfa-2b Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 1026 Citations
  • 15 h-Index
  • 34 Article
  • 1 Comment/debate

Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway

Cristiani, C. M., Turdo, A., Ventura, V., Apuzzo, T., Capone, M., Madonna, G., Mallardo, D., Garofalo, C., Giovannone, E. D., Grimaldi, A. M., Tallerico, R., Marcenaro, E., Pesce, S., Zotto, G. D., Agosti, V., Costanzo, F. S., Gulletta, E., Rizzo, A., Moretta, A., Karre, K. & 3 others, Ascierto, P. A., Todaro, M. & Carbone, E., May 2019, In : Cancer immunology research. 7, 5, p. 841-852 12 p.

Research output: Contribution to journalArticle

Natural Killer Cells
Neoplastic Stem Cells
T-Lymphocyte Subsets

Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma

Harder, N., Schönmeyer, R., Nekolla, K., Meier, A., Brieu, N., Vanegas, C., Madonna, G., Capone, M., Botti, G., Ascierto, P. A. & Schmidt, G., Dec 1 2019, In : Scientific Reports. 9, 1, 7449.

Research output: Contribution to journalArticle

Open Access
Routine Diagnostic Tests
Tumor-Infiltrating Lymphocytes
Decision Trees
Precision Medicine
2 Citations (Scopus)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations

Ascierto, P. A., Capone, M., Grimaldi, A. M., Mallardo, D., Simeone, E., Madonna, G., Roder, H., Meyer, K., Asmellash, S., Oliveira, C., Roder, J. & Grigorieva, J., Mar 29 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 91.

Research output: Contribution to journalArticle

Disease-Free Survival

Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab

(IMI), O. B. O. T. I. M. I., Pistillo, M. P., Fontana, V., Morabito, A., Dozin, B., Laurent, S., Carosio, R., Banelli, B., Ferrero, F., Spano, L., Tanda, E., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Guida, M., Tommasi, S., De Galitiis, F., Pagani, E., Antonini Cappellini, G. C., Marchetti, P. & 9 others, Quaglino, P., Fava, P., Osella-Abate, S., Ascierto, P. A., Capone, M., Simeone, E., Romani, M., Spagnolo, F. & Queirolo, P., 2019, In : Cancer Immunology and Immunotherapy.

Research output: Contribution to journalArticle

Survival Analysis
14 Citations (Scopus)

A serum protein signature associated with outcome after anti-PD-1 therapy in metastatic melanoma

Weber, J. S., Sznol, M., Sullivan, R. J., Blackmon, S., Boland, G., Kluger, H. M., Halaban, R., Bacchiocchi, A., Ascierto, P. A., Capone, M., Oliveira, C., Meyer, K., Grigorieva, J., Asmellash, S. G., Roder, J. & Roder, H., Jan 1 2018, In : Cancer immunology research. 6, 1, p. 79-86 8 p.

Research output: Contribution to journalArticle

Blood Proteins
Mass Spectrometry
Acute-Phase Proteins